Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Our latest developments

24 resultaten, getoond 1 t/m 5

Sex hormones determine the risk of liver damage in children with overweight

Informatietype:
News
28 July 2026
Research by Maastricht UMC+ and TNO shows that oestradiol protects against liver damage, while androgens such as testosterone are associated with an increased risk, in both girls and boys.

14C-Pulse-Chase Technology

Informatietype:
Article

Obesity

Informatietype:
Article

Diabetic kidney disease

Informatietype:
Article

MASH and liver fibrosis

Informatietype:
Article